Ramaswami, U., Beck, M., Hughes, D., Kampmann, C., Botha, J., Pintos-Morell, G., . . . Giugliani, R. (2019). Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis. Drug Des Devel Ther.
استشهاد بنمط شيكاغوRamaswami, Uma, et al. "Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis." Drug Des Devel Ther 2019.
MLA استشهادRamaswami, Uma, et al. "Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis." Drug Des Devel Ther 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.